Share: Share on Facebook Share on Bsky Share on X Share on LinkedIn Share via Email Print: Print this article (photo by Susan Urmy) Stanford’s Russ Altman, M.D., Ph.D., describes how “mining” a federal drug safety database uncovered a previously unknown and potentially adverse drug interaction during the Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology. Related